{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:34:14Z","timestamp":1758710054219},"reference-count":232,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cyto.2024.156756","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:39:47Z","timestamp":1726443587000},"page":"156756","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["COVID 19: Prevention and treatment through the Indian perspective"],"prefix":"10.1016","volume":"183","author":[{"given":"Harish","family":"Chandra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpana","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartikey","family":"Kumar Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghanshyam","family":"Singh Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Pezzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Paulo Martins de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Douglas Melo Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhay","family":"Prakash Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156756_b0005","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.4081\/jphr.2020.1794","article-title":"Tackling the COVID-19 pandemic: The Bangladesh perspective","volume":"9","author":"Islam","year":"2020","journal-title":"J Public Health Res"},{"key":"10.1016\/j.cyto.2024.156756_b0010","doi-asserted-by":"crossref","unstructured":"Jabaris S SL, V A. The current situation of COVID-19 in India. Brain Behav Immun Health 2021;11:100200.","DOI":"10.1016\/j.bbih.2021.100200"},{"key":"10.1016\/j.cyto.2024.156756_b0015","first-page":"579","article-title":"Transmission dynamics of the COVID-19 epidemic in India and modeling optimal lockdown exit strategies","volume":"103","author":"Gupta","year":"2021","journal-title":"IJID"},{"key":"10.1016\/j.cyto.2024.156756_b0020","doi-asserted-by":"crossref","first-page":"33021","DOI":"10.1007\/s11356-021-13096-1","article-title":"Effect of COVID-19 lockdown on the water quality index of River Gomti, India, with potential hazard of faecal-oral transmission","volume":"28","author":"Khan","year":"2021","journal-title":"Env Sci Poll Res"},{"key":"10.1016\/j.cyto.2024.156756_b0025","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jama.2022.2832","article-title":"Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial","volume":"327","author":"Gupta","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0030","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s41027-020-00293-8","article-title":"The COVID-19 Pandemic and Internal Labour Migration in India: A \u2018Crisis of Mobility\u2019","volume":"63","author":"Irudaya Rajan","year":"2020","journal-title":"Ind J Labour Econ"},{"key":"10.1016\/j.cyto.2024.156756_b0040","first-page":"3594","volume":"11","author":"Piret","year":"2021","journal-title":"Pandemics throughout History. Front Microbiol"},{"key":"10.1016\/j.cyto.2024.156756_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12703\/r\/11-2","article-title":"Emergence of epidemic diseases: zoonoses and other origins","volume":"11","author":"Weiss","year":"2022","journal-title":"Fac Rev"},{"key":"10.1016\/j.cyto.2024.156756_b0050","unstructured":"Ramesh Chandra Dubey. Vedic Microbiology- ek vaigyanic drishti. vol. 1. 1st ed. Delhi: Aastha Prakashan; 2020."},{"key":"10.1016\/j.cyto.2024.156756_b0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The Molecular Biology of Coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.cyto.2024.156756_b0060","unstructured":"Aleem A, Akbar Samad AB, Vaqar S. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). 2023."},{"key":"10.1016\/j.cyto.2024.156756_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.cyto.2024.156756_b0070","doi-asserted-by":"crossref","unstructured":"Barreto-Vieira DF, da Silva MAN, Garcia CC, Miranda MD, Matos A da R, Caetano BC, et al. Morphology and morphogenesis of SARS-CoV-2 in Vero-E6 cells. Mem Inst Oswaldo Cruz 2021;116:e200443.","DOI":"10.1590\/0074-02760200443"},{"key":"10.1016\/j.cyto.2024.156756_b0075","doi-asserted-by":"crossref","first-page":"e1008762","DOI":"10.1371\/journal.ppat.1008762","article-title":"COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2","volume":"16","author":"Mittal","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cyto.2024.156756_b0080","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3201\/eid2705.210514","article-title":"Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa)","volume":"27","author":"Eichler","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0085","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7555\/JBR.34.20200119","article-title":"Modeling the transmission dynamics of COVID-19 epidemic: a systematic review","volume":"34","author":"Guan","year":"2020","journal-title":"J Biomed Res"},{"key":"10.1016\/j.cyto.2024.156756_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2020.110173","article-title":"A mathematical model for COVID-19 transmission dynamics with a case study of India","volume":"140","author":"Samui","year":"2020","journal-title":"Chaos Solitons Fractals"},{"key":"10.1016\/j.cyto.2024.156756_b0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12664-020-01082-3","article-title":"A guide to laboratory diagnosis of Corona Virus Disease-19 for the gastroenterologists","volume":"39","author":"Ghoshal","year":"2020","journal-title":"Ind J Gastroenterol"},{"key":"10.1016\/j.cyto.2024.156756_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/23744235.2021.1903550","article-title":"Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR","volume":"53","author":"Tsujimoto","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0105","doi-asserted-by":"crossref","first-page":"e0250202","DOI":"10.1371\/journal.pone.0250202","article-title":"Low saliva pH can yield false positives results in simple RT-LAMP-based SARS-CoV-2 diagnostic tests","volume":"16","author":"Uribe-Alvarez","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156756_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1063\/5.0021554","article-title":"Evaluation of current diagnostic methods for COVID-19","volume":"4","author":"Alpdagtas","year":"2020","journal-title":"APL Bioeng"},{"key":"10.1016\/j.cyto.2024.156756_b0115","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1021\/acsnano.0c02624","article-title":"Diagnosing COVID-19: The Disease and Tools for Detection","volume":"14","author":"Udugama","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.cyto.2024.156756_b0120","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1038\/s41467-020-19057-5","article-title":"SARS-CoV-2 viral load is associated with increased disease severity and mortality","volume":"11","author":"Fajnzylber","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2024.156756_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clinmicnews.2020.07.001","article-title":"Clinical Samples for SARS-CoV-2 Detection: Review of the Early Literature","volume":"42","author":"Martinez","year":"2020","journal-title":"Clin Microbiol Newsl"},{"key":"10.1016\/j.cyto.2024.156756_b0130","doi-asserted-by":"crossref","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020 30:3 2020;30:269\u201371.","DOI":"10.1038\/s41422-020-0282-0"},{"key":"10.1016\/j.cyto.2024.156756_b0135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/clinchem\/hvaa099","article-title":"Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2)","volume":"66","author":"Wang","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.cyto.2024.156756_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114411","article-title":"Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis","volume":"300","author":"Mart\u00edn Ram\u00edrez","year":"2022","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cyto.2024.156756_b0145","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting Diagnostic Tests for SARS-CoV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jmoldx.2021.04.014","article-title":"SARS-CoV-2 RNA Quantification Using Droplet Digital RT-PCR","volume":"23","author":"Kinloch","year":"2021","journal-title":"J Mol Diag"},{"key":"10.1016\/j.cyto.2024.156756_b0155","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan","volume":"323","author":"Wang","year":"2020","journal-title":"China. JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104455","article-title":"Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis","volume":"129","author":"Scohy","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cyto.2024.156756_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12985-021-01489-0","article-title":"False negative rate of COVID-19 PCR testing: a discordant testing analysis","volume":"18","author":"Kanji","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.cyto.2024.156756_b0170","doi-asserted-by":"crossref","unstructured":"Ravikirti, Roy R, Pattadar C, Raj R, Agarwal N, Biswas B, et al. Ivermectin as a potential treatment for mild to moderate COVID-19 \u2013 A double blind randomized placebo-controlled trial. MedRxiv 2021:2021.01.05.21249310.","DOI":"10.1101\/2021.01.05.21249310"},{"key":"10.1016\/j.cyto.2024.156756_b0175","doi-asserted-by":"crossref","first-page":"e0242958","DOI":"10.1371\/journal.pone.0242958","article-title":"False-negative results of initial RT-PCR assays for COVID-19: A systematic review","volume":"15","author":"Arevalo-Rodriguez","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156756_b0180","doi-asserted-by":"crossref","unstructured":"Jindal H, Jain S, Suvvari TK, Kutikuppala Lvs, Rackimuthu S, Rocha ICN, et al. False-Negative RT-PCR Findings and Double Mutant Variant as Factors of an Overwhelming Second Wave of COVID-19 in India: an Emerging Global Health Disaster. SN Compr Clin Med 2021;3:2383\u20138.","DOI":"10.1007\/s42399-021-01059-z"},{"key":"10.1016\/j.cyto.2024.156756_b0185","doi-asserted-by":"crossref","unstructured":"Pecoraro V, Negro A, Pirotti T, Trenti T. Estimate false\u2010negative RT\u2010PCR rates for SARS\u2010CoV\u20102. A systematic review and meta\u2010analysis. Eur J Clin Invest 2022;52: 1-7.","DOI":"10.1111\/eci.13706"},{"key":"10.1016\/j.cyto.2024.156756_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-97489-9","article-title":"Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2","volume":"11","author":"Cubas-Atienzar","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2024.156756_b0195","doi-asserted-by":"crossref","first-page":"e0245521","DOI":"10.1128\/spectrum.02455-21","article-title":"Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer","volume":"10","author":"Patriquin","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cyto.2024.156756_b0200","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1038\/s41598-021-02128-y","article-title":"A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings","volume":"11","author":"Frew","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2024.156756_b0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijmmb.2021.07.003","article-title":"Rapid antigen detection kit for the diagnosis of SARS-CoV-2 - are we missing asymptomatic patients?","volume":"39","author":"Kanaujia","year":"2021","journal-title":"Ind J Med Microbiol"},{"key":"10.1016\/j.cyto.2024.156756_b0210","doi-asserted-by":"crossref","unstructured":"Haage V, Ferreira de Oliveira-Filho E, Moreira-Soto A, K\u00fchne A, Fischer C, Sacks JA, et al. Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures. J Clin Virol 2021;138:104796.","DOI":"10.1016\/j.jcv.2021.104796"},{"key":"10.1016\/j.cyto.2024.156756_b0215","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156756_b0220","doi-asserted-by":"crossref","unstructured":"Diamond MS, Kanneganti TD. Innate immunity: the first line of defense against SARS-CoV-2. Nature Immunol 2022 23:2 2022;23:165\u201376.","DOI":"10.1038\/s41590-021-01091-0"},{"key":"10.1016\/j.cyto.2024.156756_b0225","first-page":"1","article-title":"Antibody tests for identification of current and past infection with SARS-CoV-2","volume":"2022","author":"Fox","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cyto.2024.156756_b0230","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa2034545","article-title":"Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers","volume":"384","author":"Lumley","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12879-021-06031-9","article-title":"IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays","volume":"21","author":"Shah","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0240","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1002\/cti2.1136","article-title":"Detection of IgM and IgG antibodies in patients with coronavirus disease 2019","volume":"9","author":"Hou","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.cyto.2024.156756_b0245","doi-asserted-by":"crossref","unstructured":"Pang NY-L, Pang AS-R, Chow VT, Wang D-Y. Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Mil Med Res 2021;8:47.","DOI":"10.1186\/s40779-021-00342-3"},{"key":"10.1016\/j.cyto.2024.156756_b0250","doi-asserted-by":"crossref","unstructured":"Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Med 2020 26:8 2020;26:1200\u20134.","DOI":"10.1038\/s41591-020-0965-6"},{"key":"10.1016\/j.cyto.2024.156756_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cyto.2024.156756_b0260","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0265","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","article-title":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19","volume":"147","author":"Cervia","year":"2021","journal-title":"J All Clin Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/JMDH.S290711","article-title":"Diagnostic Performance of SARS-CoV-2 IgM\/IgG Rapid Test Kits for the Detection of the Novel Coronavirus in Ethiopia","volume":"14","author":"Sisay","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.cyto.2024.156756_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.751705","article-title":"Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts","volume":"13","author":"Doba\u00f1o","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/Spectrum.00341-21","article-title":"Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects","volume":"9","author":"Wheeler","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cyto.2024.156756_b0285","first-page":"381","article-title":"Comparison of six commercially available SARS-CoV-2 antibody assays\u2014Choice of assay depends on intended use","volume":"103","author":"Nilsson","year":"2021","journal-title":"IJID"},{"key":"10.1016\/j.cyto.2024.156756_b0290","first-page":"473","article-title":"Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition","volume":"20","author":"Adnan","year":"2021","journal-title":"Https:\/\/DoiOrg\/101080\/1478721020211976144"},{"key":"10.1016\/j.cyto.2024.156756_b0295","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41598-021-82428-5","article-title":"Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan","volume":"11","author":"Nakano","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2024.156756_b0300","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jmv.26303","article-title":"Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies","volume":"93","author":"Tr\u00e9-Hardy","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.cyto.2024.156756_b0305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12985-022-01768-4","article-title":"Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections","volume":"19","author":"Luo","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.cyto.2024.156756_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.603058","article-title":"The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis","volume":"11","author":"Fu","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cyto.2024.156756_b0315","doi-asserted-by":"crossref","unstructured":"Liu G, Rusling JF. COVID-19 Antibody Tests and Their Limitations. ACS Sens 2021.","DOI":"10.1021\/acssensors.0c02621"},{"key":"10.1016\/j.cyto.2024.156756_b0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2142\/biophysico.bppb-v18.004","article-title":"Antigen tests for COVID-19","volume":"18","author":"Kyosei","year":"2021","journal-title":"Biophys Physicobiol"},{"key":"10.1016\/j.cyto.2024.156756_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.01001-21","article-title":"Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein","volume":"59","author":"Thudium","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cyto.2024.156756_b0330","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.immuni.2021.11.016","article-title":"Antigenic drift: Understanding COVID-19","volume":"54","author":"Yewdell","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156756_b0335","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1016\/j.cell.2021.09.003","article-title":"The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages","volume":"184","author":"Martin","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156756_b0340","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/JOM.0000000000002138","article-title":"False Positive Results With SARS-CoV-2 RT-PCR Tests and How to Evaluate a RT-PCR-Positive Test for the Possibility of a False Positive Result","volume":"63","author":"Braunstein","year":"2021","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.cyto.2024.156756_b0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-micro-110520-023212","article-title":"Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases","volume":"75","author":"Fung","year":"2021","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cyto.2024.156756_b0350","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMp2015897","article-title":"False Negative Tests for SARS-CoV-2 Infection \u2014 Challenges and Implications","volume":"383","author":"Woloshin","year":"2020","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0355","doi-asserted-by":"crossref","first-page":"e2444","DOI":"10.1093\/cid\/ciaa1207","article-title":"Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses","volume":"73","author":"Lustig","year":"2021","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.00514-21","article-title":"Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic","volume":"59","author":"Steinhardt","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cyto.2024.156756_b0365","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/ped.14582","article-title":"False-positive results in SARS-CoV-2 antigen test with rhinovirus-A infection","volume":"63","author":"Otake","year":"2021","journal-title":"Ped Int"},{"key":"10.1016\/j.cyto.2024.156756_b0370","doi-asserted-by":"crossref","first-page":"20282","DOI":"10.1038\/s41598-022-24411-2","article-title":"Performances of four Nucleic Acid Amplification Tests for the identification of SARS-CoV-2 in Ethiopia","volume":"12","author":"Hailemariam","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2024.156756_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.65726","article-title":"Sensitivity of ID NOW and RT\u2013PCR for detection of SARS-CoV-2 in an ambulatory population","volume":"10","author":"Tu","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.cyto.2024.156756_b0380","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12985-022-01871-6","article-title":"Performance evaluation of antigen detection rapid diagnostic test (Ag-RDT) for COVID-19 diagnosis in a primary healthcare center during the Shanghai COVID-19 quarantine period","volume":"19","author":"Dong","year":"2022","journal-title":"Virol J"},{"key":"10.1016\/j.cyto.2024.156756_b0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12985-021-01530-2","article-title":"Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients","volume":"18","author":"Chansaenroj","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.cyto.2024.156756_b0390","doi-asserted-by":"crossref","first-page":"e0099321","DOI":"10.1128\/spectrum.00993-21","article-title":"Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test","volume":"10","author":"Chan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.cyto.2024.156756_b0395","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ijmr.IJMR_860_20","article-title":"COVID-19 in India: Moving from containment to mitigation","volume":"151","author":"Varghese","year":"2020","journal-title":"Ind J Med Res"},{"key":"10.1016\/j.cyto.2024.156756_b0400","series-title":"Study and impact analysis of COVID-19 pandemic clinical data on infection spreading","first-page":"225","author":"Parida","year":"2022"},{"key":"10.1016\/j.cyto.2024.156756_b0405","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.amjms.2020.08.002","article-title":"The Coronavirus Response in India \u2013 World\u2019s Largest Lockdown","volume":"360","author":"Venkata-Subramani","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cyto.2024.156756_b0410","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1007\/s10668-020-00884-x","article-title":"Understanding COVID-19 transmission, health impacts and mitigation: timely social distancing is the key","volume":"23","author":"Kaur","year":"2021","journal-title":"Environ Dev Sustain"},{"key":"10.1016\/j.cyto.2024.156756_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.139281","article-title":"COVID-19 pandemic persuaded lockdown effects on environment over stone quarrying and crushing areas","volume":"732","author":"Mandal","year":"2020","journal-title":"Sci Total Environm"},{"key":"10.1016\/j.cyto.2024.156756_b0420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/ijpvm.IJPVM_287_20","article-title":"Lockdown-4: Impact of Lockdown on COVID-19 Scenario in India","volume":"11","author":"Pachori","year":"2020","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.cyto.2024.156756_b0425","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40001-020-00456-9","article-title":"Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries","volume":"25","author":"Meo","year":"2020","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cyto.2024.156756_b0430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/jgid.jgid_340_20","article-title":"Impacts of lockdown interventions on the spread of COVID-19 in India","volume":"13","author":"Bhardwaj","year":"2021","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0435","doi-asserted-by":"crossref","first-page":"e006653","DOI":"10.1136\/bmjgh-2021-006653","article-title":"Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19","volume":"6","author":"Meyerowitz-Katz","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.cyto.2024.156756_b0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12939-022-01666-9","article-title":"Strategies comparison in response to the two waves of COVID-19 in the United States and India","volume":"21","author":"Yang","year":"2022","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.cyto.2024.156756_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.childyouth.2020.105866","article-title":"COVID-19 and its impact on education, social life and mental health of students: A survey","volume":"121","author":"Chaturvedi","year":"2021","journal-title":"Child Youth Serv Rev"},{"key":"10.1016\/j.cyto.2024.156756_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.sintl.2020.100021","article-title":"How India is dealing with COVID-19 pandemic","volume":"1","author":"Ghosh","year":"2020","journal-title":"Sensors Int"},{"key":"10.1016\/j.cyto.2024.156756_b0455","article-title":"Analysis of the COVID-19 impacts on employment and unemployment across the multi-dimensional social disadvantaged areas","volume":"4","author":"Antipova","year":"2021","journal-title":"Social Sci Human Open"},{"key":"10.1016\/j.cyto.2024.156756_b0460","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10645-022-09406-8","article-title":"The Short-Term Effect of the COVID-19 Crisis on Employment Probabilities of Labour-Market Entrants in the Netherlands","volume":"170","author":"Bussink","year":"2022","journal-title":"Economist (leideN)"},{"key":"10.1016\/j.cyto.2024.156756_b0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s42979-020-00410-w","article-title":"A Statistical Analysis of Impact of COVID19 on the Global Economy and Stock Index Returns","volume":"2","author":"Verma","year":"2021","journal-title":"SN Comput Sci"},{"key":"10.1016\/j.cyto.2024.156756_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114762","article-title":"The effects of India\u2019s COVID-19 lockdown on critical non-COVID health care and outcomes: Evidence from dialysis patients","volume":"296","author":"Jain","year":"2022","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.cyto.2024.156756_b0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amsu.2020.06.010","article-title":"Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective","volume":"56","author":"Atalan","year":"2020","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.cyto.2024.156756_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101802","article-title":"Positive impact of lockdown on COVID-19 outbreak in Thailand","volume":"36","author":"Dechsupa","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2020.110078","article-title":"Assessment of lockdown effect in some states and overall India: A predictive mathematical study on COVID-19 outbreak","volume":"139","author":"Sardar","year":"2020","journal-title":"Chaos Solitons Fractals"},{"key":"10.1016\/j.cyto.2024.156756_b0490","first-page":"33","article-title":"Understanding the devastating second wave of <scp>COVID<\/scp> -19 pandemic in India","author":"Chinnaswamy","year":"2021","journal-title":"Am J Human Biol"},{"key":"10.1016\/j.cyto.2024.156756_b0495","doi-asserted-by":"crossref","first-page":"100 . y","DOI":"10.1140\/epjp\/s13360-021-02321-y","article-title":"Omicron: a mysterious variant of concern","volume":"137","author":"Gowrisankar","year":"2022","journal-title":"Eur Phys J plus"},{"key":"10.1016\/j.cyto.2024.156756_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2020.100736","article-title":"SARS-CoV-2 pandemic: An overview","volume":"77","author":"Acuti Martellucci","year":"2020","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.cyto.2024.156756_b0505","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jiac.2022.10.008","article-title":"Favipiravir for symptomatic COVID-19: A nationwide observational cohort study","volume":"29","author":"Doi","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cyto.2024.156756_b0510","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00705-021-04956-9","article-title":"Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study","volume":"166","author":"Dabbous","year":"2021","journal-title":"Arch Virol"},{"key":"10.1016\/j.cyto.2024.156756_b0515","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.1073\/pnas.1811345115","article-title":"The mechanism of resistance to favipiravir in influenza","volume":"115","author":"Goldhill","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cyto.2024.156756_b0520","unstructured":"Du Y, Chen X. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019\u2010nCoV."},{"key":"10.1016\/j.cyto.2024.156756_b0525","first-page":"501","article-title":"Role of favipiravir in the treatment of COVID-19","volume":"102","author":"Joshi","year":"2021","journal-title":"IJID"},{"key":"10.1016\/j.cyto.2024.156756_b0530","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2213-2600(22)00412-X","article-title":"Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care","volume":"11","author":"Shah","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cyto.2024.156756_b0535","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2024.156756_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cyto.2024.156756_b0545","doi-asserted-by":"crossref","unstructured":"Mahase E. Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports. BMJ 2021:n2422: 23-45.","DOI":"10.1136\/bmj.n2422"},{"key":"10.1016\/j.cyto.2024.156756_b0550","first-page":"25","article-title":"Phase 2\/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults","volume":"1","author":"Caraco","year":"2021","journal-title":"NEJM Evid"},{"key":"10.1016\/j.cyto.2024.156756_b0555","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0560","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.cyto.2024.156756_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109075","article-title":"Current evidence on the use of anakinra in COVID-19","volume":"111","author":"Khani","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.cyto.2024.156756_b0570","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.4103\/jfmpc.jfmpc_1338_21","article-title":"Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease: A potential game-changer","volume":"10","author":"Sahu","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.cyto.2024.156756_b0575","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cyto.2024.156756_b0580","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/brv.12140","article-title":"The return of metabolism: biochemistry and physiology of the pentose phosphate pathway","volume":"90","author":"Stincone","year":"2015","journal-title":"Biol Rev"},{"key":"10.1016\/j.cyto.2024.156756_b0585","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/metabo11100699","article-title":"Targeting the pentose phosphate pathway for sars-cov-2 therapy","volume":"11","author":"Bojkova","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.cyto.2024.156756_b0590","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase i dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cyto.2024.156756_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cyto.2024.156756_b0600","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1097\/MJT.0000000000001402","article-title":"Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines","volume":"28","author":"Bryant","year":"2021","journal-title":"Am J Ther"},{"key":"10.1016\/j.cyto.2024.156756_b0605","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa2115869","article-title":"Effect of Early Treatment with Ivermectin among Patients with Covid-19","volume":"386","author":"Reis","year":"2022","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0610","first-page":"1","article-title":"Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data","volume":"369","author":"Mah\u00e9vas","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cyto.2024.156756_b0615","unstructured":"Mitj\u00e0 O, Group BPP for C type-2 (BCN P-C-2) R, Corbacho-Monn\u00e9 M, Group BPP for C type-2 (BCN P-C-2) R, Ubals M, Group BPP for C type-2 (BCN P-C-2) R, et al. Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial. Clin Infect Dis 2021;73:e4073\u201381."},{"key":"10.1016\/j.cyto.2024.156756_b0620","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/TCRM.S301817","article-title":"Chloroquine and hydroxychloroquine for the prevention and treatment of covid-19: A fiction, hope or hype? an updated review","volume":"17","author":"Saghir","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.cyto.2024.156756_b0625","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/ciaa237","article-title":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","volume":"71","author":"Yao","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-019-0132-8","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.cyto.2024.156756_b0635","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.cyto.2024.156756_b0640","doi-asserted-by":"crossref","unstructured":"Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, et al. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. MedRxiv 2020:2020.03.22.20040758.","DOI":"10.1101\/2020.03.22.20040758"},{"key":"10.1016\/j.cyto.2024.156756_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cyto.2024.156756_b0650","doi-asserted-by":"crossref","first-page":"e0257238","DOI":"10.1371\/journal.pone.0257238","article-title":"Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: A randomized controlled trial","volume":"16","author":"Hernandez-Cardenas","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2024.156756_b0655","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/jama.2020.22240","article-title":"Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial","volume":"324","author":"Self","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0660","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/cid\/ciaa721","article-title":"Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients","volume":"71","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0665","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.cyto.2024.156756_b0670","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0675","doi-asserted-by":"crossref","first-page":"e2250647","DOI":"10.1001\/jamanetworkopen.2022.50647","article-title":"COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis","volume":"6","author":"Senefeld","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cyto.2024.156756_b0680","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fimmu.2022.817829","article-title":"Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis","volume":"13","author":"Jorda","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0685","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ilar.46.3.258","article-title":"Monoclonal Versus Polyclonal Antibodies: Distinguishing Characteristics, Applications, and Information Resources","volume":"46","author":"Lipman","year":"2005","journal-title":"ILAR J"},{"key":"10.1016\/j.cyto.2024.156756_b0690","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042921-112837","volume":"74","author":"Cron","year":"2023","journal-title":"Cytokine Storm Syndrome. Ann Rev Med"},{"key":"10.1016\/j.cyto.2024.156756_b0695","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0700","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jama.2021.9508","article-title":"Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial","volume":"326","author":"Caricchio","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110812","article-title":"LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants","volume":"39","author":"Westendorf","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.cyto.2024.156756_b0710","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","article-title":"Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19","volume":"385","author":"Dougan","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0715","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s40265-021-01620-z","article-title":"Casirivimab\/Imdevimab: First Approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.cyto.2024.156756_b0720","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0725","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab\u2013Cilgavimab) for Prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0730","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.annonc.2020.03.300","article-title":"Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report","volume":"31","author":"Michot","year":"2020","journal-title":"Annals Oncol"},{"key":"10.1016\/j.cyto.2024.156756_b0735","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08830185.2021.1884248","article-title":"Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality","volume":"41","author":"Que","year":"2022","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0740","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156756_b0745","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/cti.2015.14","article-title":"Clinical development methodology for infusion-related reactions with monoclonal antibodies","volume":"4","author":"Doessegger","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.cyto.2024.156756_b0750","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/1744666X.2019.1562905","article-title":"Infusion-related reactions to rituximab: frequency, mechanisms and predictors","volume":"15","author":"Paul","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0755","first-page":"245","article-title":"Exploring the potency of Ayurveda in pandemic caused by COVID-19 on scientific parameters","volume":"19","author":"Chaudhary","year":"2021","journal-title":"Indian J Trad Know"},{"key":"10.1016\/j.cyto.2024.156756_b0760","first-page":"245","article-title":"Role of Indian traditional medicine in mitigating novel corona virus effects","volume":"19","author":"Rao","year":"2020","journal-title":"Indian J Trad Know"},{"key":"10.1016\/j.cyto.2024.156756_b0765","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jwip.12220","article-title":"Role of traditional knowledge in the COVID-19 battle","volume":"25","author":"Ola","year":"2022","journal-title":"J World Intellect Prop"},{"key":"10.1016\/j.cyto.2024.156756_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109848","article-title":"Potential role of zinc supplementation in prophylaxis and treatment of COVID-19","volume":"144","author":"Kumar","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cyto.2024.156756_b0775","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1002\/fsn3.1858","article-title":"Curcumin (a constituent of turmeric): New treatment option against COVID-19","volume":"8","author":"Babaei","year":"2020","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.cyto.2024.156756_b0780","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4149\/av_2020_309","article-title":"Potential therapeutic effects of Resveratrol against SARS-CoV-2","volume":"64","author":"Ramdani","year":"2020","journal-title":"Acta Virol"},{"key":"10.1016\/j.cyto.2024.156756_b0785","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40261-020-00933-3","article-title":"Azithromycin for COVID-19: More Than Just an Antimicrobial?","volume":"40","author":"Bleyzac","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.cyto.2024.156756_b0790","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fimmu.2020.01712","article-title":"The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis","volume":"11","author":"Wessels","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0795","doi-asserted-by":"crossref","unstructured":"Pedrosa AM da C, Weinlich R, Mognol GP, Robbs BK, Viola JP de B, Campa A, et al. Melatonin Protects CD4+ T Cells from Activation-Induced Cell Death by Blocking NFAT-Mediated CD95 Ligand Upregulation. J Immunol 2010;184:3487\u201394.","DOI":"10.4049\/jimmunol.0902961"},{"key":"10.1016\/j.cyto.2024.156756_b0800","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thrombosis Haemostasis"},{"key":"10.1016\/j.cyto.2024.156756_b0805","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fphar.2022.836738","article-title":"The Role of Vitamin D in COVID-19 and the Impact of Pandemic Restrictions on Vitamin D Blood Content","volume":"13","author":"Tomaszewska","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cyto.2024.156756_b0810","doi-asserted-by":"crossref","first-page":"L20","DOI":"10.1152\/ajplung.00300.2011","article-title":"Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid","volume":"303","author":"Fisher","year":"2012","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"10.1016\/j.cyto.2024.156756_b0815","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.cyto.2024.156756_b0820","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.00819-20","article-title":"Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs","volume":"64","author":"Jeon","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cyto.2024.156756_b0825","article-title":"The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15","author":"Matsuyama","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.cyto.2024.156756_b0830","first-page":"332","volume":"5","author":"Atamas","year":"2013","journal-title":"Cytokines in Chronic Respiratory Diseases. F1000 Biol Rep"},{"key":"10.1016\/j.cyto.2024.156756_b0835","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fphar.2021.664349","article-title":"Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential","volume":"12","author":"Cui","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cyto.2024.156756_b0840","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/bj3180325","article-title":"Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation","volume":"318","author":"Ristim\u00e4ki","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.cyto.2024.156756_b0845","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/jme.0.0280069","article-title":"Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids","volume":"28","author":"Almawi","year":"2002","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.cyto.2024.156756_b0850","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12879-021-06045-3","article-title":"Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial","volume":"21","author":"Ranjbar","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0855","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156756_b0860","unstructured":"Yang Z, Liu J, Zhou Y, Zhao X, Zhao Q, Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infection."},{"key":"10.1016\/j.cyto.2024.156756_b0865","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5694\/mja2.50577","article-title":"Corticosteroid treatment of patients with coronavirus disease 2019 (<scp>COVID<\/scp> -19)","volume":"212","author":"Zha","year":"2020","journal-title":"Med J Australia"},{"key":"10.1016\/j.cyto.2024.156756_b0870","doi-asserted-by":"crossref","first-page":"2300270","DOI":"10.1183\/13993003.00270-2023","article-title":"A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet","volume":"61","author":"Nigro","year":"2023","journal-title":"Eur Resp J"},{"key":"10.1016\/j.cyto.2024.156756_b0875","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0880","doi-asserted-by":"crossref","first-page":"e06576","DOI":"10.1016\/j.heliyon.2021.e06576","article-title":"Environmental correlation and epidemiologic analysis of COVID-19 pandemic in ten regions in five continents","volume":"7","author":"Sharif","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.cyto.2024.156756_b0885","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/pai.13298","article-title":"African American children are at higher risk of COVID-19 infection","volume":"31","author":"Bandi","year":"2020","journal-title":"Ped Allergy Immunol"},{"key":"10.1016\/j.cyto.2024.156756_b0890","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pedn.2022.01.015","article-title":"Vaccination for COVID-19 in children: Denialism or misinformation?","volume":"64","author":"de Albuquerque","year":"2022","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/j.cyto.2024.156756_b0895","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A systematic review of SARS-CoV-2 vaccine candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.cyto.2024.156756_b0900","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/vaccines9050467","article-title":"Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"9","author":"Pormohammad","year":"2021","journal-title":"Vaccines (baseL)"},{"key":"10.1016\/j.cyto.2024.156756_b0905","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","article-title":"Next-generation vaccine platforms for COVID-19","volume":"19","author":"van Riel","year":"2020","journal-title":"Nat Mater"},{"key":"10.1016\/j.cyto.2024.156756_b0910","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2024.156756_b0915","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Shinde","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0920","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156756_b0925","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156756_b0930","doi-asserted-by":"crossref","unstructured":"Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. PhaseI\/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 2020 586:7830 2020;586:589\u201393.","DOI":"10.1038\/s41586-020-2639-4"},{"key":"10.1016\/j.cyto.2024.156756_b0935","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0940","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(21)00200-0","article-title":"Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"21","author":"Chappell","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0945","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2024.156756_b0950","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0140-6736(21)00191-4","article-title":"Sputnik V COVID-19 vaccine candidate appears safe and effective","volume":"397","author":"Jones","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156756_b0955","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0960","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156756_b0965","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim Results of a Phase 1\u20132a Trial of Ad26.COV2.S Covid-19 Vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0970","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1\u20132 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"New England J Med"},{"key":"10.1016\/j.cyto.2024.156756_b0975","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2020.15543","article-title":"Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials","volume":"324","author":"Xia","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2024.156756_b0980","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0985","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1473-3099(20)30942-7","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial","volume":"21","author":"Ella","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cyto.2024.156756_b0990","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(21)02753-7","volume":"399","author":"Halperin","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2024.156756_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100141","article-title":"Herbal medicine use for the management of COVID-19: A review article","volume":"12","author":"Demeke","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.cyto.2024.156756_b1000","doi-asserted-by":"crossref","unstructured":"Ahmad S, Zahiruddin S, Parveen B, Basist P, Parveen A, Gaurav, et al. Indian Medicinal Plants and Formulations and Their Potential Against COVID-19\u2013Preclinical and Clinical Research. Front Pharmacol 2021;11:2470.","DOI":"10.3389\/fphar.2020.578970"},{"key":"10.1016\/j.cyto.2024.156756_b1005","unstructured":"Ahmad S, Abbasi HW, Shahid S, Gul S, Abbasi SW. Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment."},{"key":"10.1016\/j.cyto.2024.156756_b1010","unstructured":"Mohapatra PK, Chopdar KS, Dash GC, Mohanty AK, Raval MK. In silico screening and covalent binding of phytochemicals of Ocimum sanctum against SARS-CoV-2 (COVID 19) main protease."},{"key":"10.1016\/j.cyto.2024.156756_b1015","doi-asserted-by":"crossref","unstructured":"Xie Z, Li Y, Liu Z, Zeng M, Moore JC, Gao B, et al. Bioactive Compositions of Cinnamon (Cinnamomum verum J. Presl) Extracts and Their Capacities in Suppressing SARS-CoV-2 Spike Protein Binding to ACE2, Inhibiting ACE2, and Scavenging Free Radicals. J Agric Food Chem 2023;71:4890\u2013900.","DOI":"10.1021\/acs.jafc.3c00285"},{"key":"10.1016\/j.cyto.2024.156756_b1020","doi-asserted-by":"crossref","unstructured":"Maulani Wijaya R, Aldino Hafidzhah M, Dhea Kharisma V, Nur Muhammad Ansori A, Aditya Parikesit A, Maulani R, et al. COVID-19 In Silico Drug with Zingiber officinale Natural Product Compound Library Targeting the Mpro Protein. Makara J Sci 2021;25:5.","DOI":"10.7454\/mss.v25i3.1244"},{"key":"10.1016\/j.cyto.2024.156756_b1025","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.18520\/cs\/v119\/i8\/1333-1342","article-title":"Computational studies reveal piperine, the predominant oleoresin of black pepper (Piper nigrum) as a potential inhibitor of SARS-CoV-2 (COVID-19)","volume":"119","author":"Choudhary","year":"2020","journal-title":"Curr Sci"},{"key":"10.1016\/j.cyto.2024.156756_b1030","doi-asserted-by":"crossref","unstructured":"Kumar V, Singh SB, Singh S. Pharmacological Perspectives of Ayurvedic Herbs viz. Alstonia scholaris L., Picrorhiza kurroa, Swertia chirata and Caesalpinia crista Against COVID-19: A Mini-Review. Mini Rev Org Chem 2021;18:841\u20139.","DOI":"10.2174\/1570193X17999201102200944"},{"key":"10.1016\/j.cyto.2024.156756_b1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2021.02.004","article-title":"In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease","volume":"13","author":"Ram","year":"2022","journal-title":"J Ayurveda Integr Med"},{"key":"10.1016\/j.cyto.2024.156756_b1040","unstructured":"Rathi B. Tinospora Cordifolia-An immunomodulatory drug in Ayurveda for prevention and treatment of Covid-19 teaching-learning methodology in Kaumarabhritya View project Medicine View project. J Res Pharma Sci 2020."},{"key":"10.1016\/j.cyto.2024.156756_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2020.10.012","article-title":"A critical analysis of CTRI registered AYUSH studies for COVID- 19","volume":"13","author":"Bhapkar","year":"2022","journal-title":"J Ayurveda Integr Med"},{"key":"10.1016\/j.cyto.2024.156756_b1050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000517924","article-title":"Homeopathic Treatment for COVID-19-Related Symptoms: A Case Series","volume":"29","author":"Kurd","year":"2022","journal-title":"Complement Med Res"},{"key":"10.1016\/j.cyto.2024.156756_b1055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.joim.2022.03.003","article-title":"Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study)","volume":"20","author":"Adler","year":"2022","journal-title":"J Integr Med"},{"key":"10.1016\/j.cyto.2024.156756_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2022.101602","article-title":"Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study","volume":"48","author":"Nayak","year":"2022","journal-title":"Complement Ther Clin Pract"},{"key":"10.1016\/j.cyto.2024.156756_b1065","article-title":"Influenza-1918: Homeopathy to the Rescue | New England School of Homeopathy","volume":"7","author":"Winston","year":"1998","journal-title":"New England J Homeopathy"},{"key":"10.1016\/j.cyto.2024.156756_b1070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.51910\/ijhdr.v7i25.315","article-title":"Contribution of homeopathy to the control of an outbreak of dengue in Maca\u00e9, Rio de Janeiro","volume":"7","author":"De Souza Nunes","year":"2021","journal-title":"Int J High Dilution Res"},{"key":"10.1016\/j.cyto.2024.156756_b1075","doi-asserted-by":"crossref","unstructured":"Gosik MS, Mendes MFX, Werneck dos Santos LM de A, Barbas D da S, Cabo DJV do, Strastis H, et al. Medicines for the new coronavirus in the view of Classical Systemic Homeopathy. Complement Ther Clin Pract 2021;45:101482.","DOI":"10.1016\/j.ctcp.2021.101482"},{"key":"10.1016\/j.cyto.2024.156756_b1080","article-title":"Homeopathic Remedies in COVID-19: Prognostic Factor Research","author":"Manchanda","year":"2021","journal-title":"Homeopathy"},{"key":"10.1016\/j.cyto.2024.156756_b1085","doi-asserted-by":"crossref","unstructured":"Peckham EJ, Cooper K, Roberts ER, Agrawal A, Brabyn S, Tew G. Homeopathy for treatment of irritable bowel syndrome. Cochrane Database of Syst Rev 2019;2019.","DOI":"10.1002\/14651858.CD009710.pub3"},{"key":"10.1016\/j.cyto.2024.156756_b1090","article-title":"Homeopathy in the treatment of COVID-19","volume":"20","author":"Holandino","year":"2021","journal-title":"Int J High Dil Res"},{"key":"10.1016\/j.cyto.2024.156756_b1095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3233\/WOR-203219","article-title":"The role of Yoga in working from home during the COVID-19 global lockdown","volume":"66","author":"Sharma","year":"2020","journal-title":"Work"},{"key":"10.1016\/j.cyto.2024.156756_b1100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/ijoy.IJOY_27_20","article-title":"Yoga for COVID-19","volume":"13","author":"Nagendra","year":"2020","journal-title":"Int J Yoga"},{"key":"10.1016\/j.cyto.2024.156756_b1105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/ijoy.IJOY_22_20","article-title":"A perspective on yoga as a preventive strategy for coronavirus disease 2019","volume":"13","author":"Nagarathna","year":"2020","journal-title":"Int J Yoga"},{"key":"10.1016\/j.cyto.2024.156756_b1110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10865-018-9914-y","article-title":"Yoga and immune system functioning: a systematic review of randomized controlled trials","volume":"41","author":"Falkenberg","year":"2018","journal-title":"J Behav Med"},{"key":"10.1016\/j.cyto.2024.156756_b1115","doi-asserted-by":"crossref","DOI":"10.4103\/2348-8093.143474","article-title":"Role of yoga in hormonal homeostasis","volume":"1","author":"Mahajan","year":"2014","journal-title":"Int J Clin Exp Physiol"},{"key":"10.1016\/j.cyto.2024.156756_b1120","first-page":"37","article-title":"Effect Of Yoga Practices On Respiratory Parameters In Healthy Young Adults","volume":"5","author":"Parikh","year":"2014","journal-title":"Natl J Integr Res Med"},{"key":"10.1016\/j.cyto.2024.156756_b1125","doi-asserted-by":"crossref","unstructured":"Bagade AH, Harish Bagade A, Shrikrishna Bhonde M, Dhokane NB. Effect of Pranayama on respiratory endurance in young adults. Natl J Physiol Pharma Pharmacol 2018.","DOI":"10.5455\/njppp.2018.8.0301028042018"},{"key":"10.1016\/j.cyto.2024.156756_b1130","first-page":"1","article-title":"Effect of yogic exercise on respiratory system in middle aged men","volume":"4","author":"Kadu","year":"2013","journal-title":"J Physiol Pathophysiol"},{"key":"10.1016\/j.cyto.2024.156756_b1135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/ijoy.IJOY_37_19","article-title":"Exploring the therapeutic benefits of Pranayama (yogic breathing): A systematic review","volume":"13","author":"Jayawardena","year":"2020","journal-title":"Int J Yoga"},{"key":"10.1016\/j.cyto.2024.156756_b1140","first-page":"12","article-title":"EFEECT OF PRANAYAMA (YOGA) ON PULMONARY FUNCTION TEST OF YOUNG HEALTHY STUDENTS","volume":"3","author":"Sheetal Panwar","year":"2012","journal-title":"Int J Pharm Bio Sci"},{"key":"10.1016\/j.cyto.2024.156756_b1145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.26452\/ijrps.v11iSPL1.2717","article-title":"Agnihotra (Homa)- an Ayurveda therapy in the prevention and control of covid-19","volume":"11","author":"Deogade","year":"2020","journal-title":"Int J Res Pharma Sci"},{"key":"10.1016\/j.cyto.2024.156756_b1150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/joa.joa_275_20","article-title":"Could Agnihotra yagya have any role in the prevention and management of epidemics as COVID-19: A scientific perspective","volume":"16","author":"Singh","year":"2022","journal-title":"J Ayurveda"},{"key":"10.1016\/j.cyto.2024.156756_b1155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.24321\/2394.6539.202009","article-title":"Virucidal Effect of Medicinal Smoke for Mass Fumigation using Hawan Techniques during SARS-CoV-2 Pandemic: A Review","volume":"07","author":"Kumar","year":"2020","journal-title":"J Adv Res Med Sci Technol"},{"key":"10.1016\/j.cyto.2024.156756_b1160","unstructured":"Ramesh Chandra Dubey. Vedic Microbiology: A Scientific Approach. vol. 1. 1st ed. Delhi: Motilal Banarsidass; 2021."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:57:05Z","timestamp":1727121425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":232,"alternative-id":["S1043466624002606"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156756","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID 19: Prevention and treatment through the Indian perspective","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156756"}}